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RESULTS: Productivity losses associated with a primary
diagnosis of allergic rhinitis in the 1995 NHIS were esti-
mated to be $601 million. These costs increased to $733
million when secondary diagnoses of allergic rhinitis
were also considered. When additional survey informa-
tion on the use of sedating over-the-counter allergy medi-
cations, as well as workers’ self-assessments of their re-
duction in at-work productivity due to allergic rhinitis
were considered, the productivity cost estimates in-
creased dramatically. At-work productivity losses were
estimated to range from $2.4 to $4.6 billion using differ-
ent estimates of on-the-job productivity reductions avail-
able from the literature. It should be noted that the most
significant productivity losses did not occur through ab-
sence related to allergies but, rather, through reduced at-
work productivity associated with the use of sedating
over-the-counter antihistamines.
CONCLUSIONS: Despite the inevitable imprecision in
any productivity loss estimate it is important to note that
even our lowest estimate is several times higher than pre-
vious estimates of the indirect medical costs associated
with treating allergic rhinitis.
TPIC4
QUANTIFICATION OF INDIRECT BENEFITS 
FROM MORBIDITY AND MORTALITY 
REDUCTION: APPLICATION TO PHARMACY 
SERVICES PROGRAM EVALUATION
Lai L1, Sorkin A2
1Nova Southeastern University, Ft. Lauderdale, FL, USA; 2Johns 
Hopkins University/University of Maryland, Baltimore, MD, 
USA
Cost-benefit analysis has been applied in health and
pharmacy related studies for years. In most cost-benefit
analysis used to evaluate health services programs, the
net economic benefits are limited to the direct benefits
such as reduction in costs of medication, hospitalization,
etc. Not many of them addressed the indirect benefits
from morbidity/mortality reduction.
OBJECTIVE: The purpose of this study was to estimate
the indirect benefits from morbidity and mortality reduc-
tion.
METHODS: Our approach to measuring the mortality ef-
fects of disease was to apply Weisbrod’s economic theory
that estimated costs as the product of number of deaths
and expected value of an individual’s future earnings tak-
ing into account age and sex. This method considers life
expectancy for different age and sex groups, changing pat-
terns of earnings at successive ages, varying labor force
participation rates, imputed value for housewives’ services,
and the appropriate discount rate to convert a stream of
costs or benefits into its present worth. The losses from
morbidity were defined as the temporary losses of a pro-
ducer due to poor health. The morbidity losses for any dis-
ease could be determined if we know the age and sex inci-
dence of the disease, the average duration of illness it
causes, and the average earnings of target population.
RESULTS AND CONCLUSIONS: We applied this meth-
odology to estimate the indirect benefits of a pharmaceuti-
cal care intervention program to Maryland Medicaid pa-
tients. The results show the estimated monetary benefits of
the intervention from the reduction in mortality was
$901,980.20, from morbidity was $3840.00 for the first
year and $29,651.40 for the next 10 years.
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A cost-efficient data collection method, with high re-
sponse rates over repeated administrations, is desirable
for collecting longitudinal self-reported data.
OBJECTIVES: The purpose of this study was to deter-
mine the response rate to telephonic collection of data in
an ongoing study to assess HCU and PL associated with
influenza in an employed population.
METHODS: An employer site conducting an annual in-
fluenza vaccination program was selected for the ongoing
5-month study. Subjects were recruited on-site and self-
administered baseline paper-based health outcomes sur-
veys. Subjects provided preferred times and telephone
numbers where they could be reached and were encour-
aged to record HCU and PL due to illness in diaries pro-
vided. Self-reported HCU and PL during the preceding
month were collected during the monthly telephone fol-
low-up. Self-reported vaccination status at baseline and
telephone follow-up were contrasted to estimate reliabil-
ity. A maximum of three call attempts and branched
logic were used to ensure cost-efficient call completion.
RESULTS: A total of 1489 subjects were recruited and
completed the baseline surveys. A total of 1443 subjects
were contacted, of which 1101 completed the month 1
surveys for an effective response rate of 76%. On aver-
age, two call attempts were required for initial contact,
with a mean telephone survey time of 1.5 minutes for
healthy subjects and 2.5 minutes for subjects reporting an
illness. Of 1101 subjects, 1080 subjects indicated identi-
cal vaccination status at baseline and telephone follow-
up representing 98% concordance.
CONCLUSIONS: Telephony may reliably offer higher
response rates at a comparable cost to mailed surveys to
gather self-reported data such as HCU and PL.
